Intermountain Healthcare

Intermountain Healthcare is a nonprofit health system headquartered in Salt Lake City, Utah. It operates 22 hospitals and employs approximately 1,100 primary and secondary care physicians across more than 185 clinics within the Intermountain Medical Group. As the largest healthcare provider in the Intermountain West, the organization serves the healthcare needs of residents in Utah and southeastern Idaho, employing over 33,000 individuals. Intermountain Healthcare offers a comprehensive range of medical services, including specialties in cancer, heart health, women's health, newborn care, orthopedics, sports medicine, and diagnostics, among others. In addition to clinical services, the organization also provides health insurance plans through SelectHealth, reinforcing its commitment to delivering high-quality healthcare to the communities it serves.

Robert Allen

President, CEO and Board Member

Nannette Berensen

COO

Erik Decker

Vice President and Chief Information Security Officer

Bert Zimmerli

Senior VP, CFO

24 past transactions

Foodsmart

Series C in 2024
Foodsmart is a digital nutrition platform focused on enhancing health outcomes through personalized dietary recommendations. The company aims to support individuals dealing with chronic diseases and food insecurity by collaborating with health plans and healthcare providers. Its online telehealth application offers real-time guidance across various settings, including homes, workplaces, grocery stores, and restaurants. This comprehensive approach enables users to make healthier food choices and select recipes that can mitigate chronic health issues, thereby promoting overall well-being. By providing access to affordable and tailored healthy eating options, Foodsmart strives to empower individuals to improve their nutrition and health.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of innovative cell therapies. The company has developed a microfluidic platform aimed at optimizing the detection of rare circulating tumor cells, which can be critical in cancer diagnostics. This platform is designed to facilitate the creation of liquid biopsy tests that predict patient responses to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to enhance the precision of cancer treatment and improve patient outcomes.

Tepeyac Community Health Center

Grant in 2022
Tepeyac Community Health Center is a non-profit community health center in Denver that has been providing care to the medically underserved.

Teton Simulation

Acquisition in 2022
Teton Simulation is a software company specializing in automatic validation and optimization of 3D print parameters. Its technology replaces traditional print-break-repeat prototyping cycles, accelerating product development and reducing production time and costs. Users can create applications leveraging structural behavior and progressive failure analysis.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

SCL Health

Acquisition in 2021
SCL Health is a faith-based, nonprofit healthcare organization dedicated to improving the health of the people and communities we serve, especially those who are poor and vulnerable. Founded by the Sisters of Charity of Leavenworth in 1864, our $2.5 billion health network provides comprehensive, coordinated care through 11 hospitals, more than 100 physician clinics, and home health, hospice, mental health and safety-net services primarily in Colorado and Montana. We relentlessly focus on delivering safe, high-quality, effective care to every patient, every time, everywhere. In 2016, SCL Health invested $257 million in community benefit —10 cents of every dollar we earn—to support health improvement in our communities.

Vori Health

Series A in 2021
Vori Health is a healthcare organization that specializes in the treatment of musculoskeletal conditions through an innovative care delivery model. Established in 2020 and headquartered in New York, Vori Health provides a comprehensive range of services, including integrated medical and rehabilitation care, physical therapy, prescription management, imaging and lab ordering, health coaching, nutritional guidance, and community support. The company employs a virtual-first approach, connecting patients with a trained care team that includes board-certified, non-operative physical medicine physicians, health coach navigators, and physical therapists. This collaborative model ensures thorough initial assessments and coordinated care, aimed at guiding patients through their wellness journeys, particularly in addressing issues related to the back, neck, and joints.

Classic Air Medical

Acquisition in 2021
Classic Air Medical is a provider of air medical transport services operating in Arizona, Utah, Colorado, Idaho, New Mexico, and Wyoming. The company specializes in critical care air transport, utilizing both rotor and fixed-wing aircraft to facilitate rapid medical evacuations from rural hospitals and emergency scenes. With a strong emphasis on patient care and safety, Classic Air Medical not only delivers essential transport services but also engages in community health education to ensure patients receive safe and efficient air medical care.

Recursion Pharmaceuticals

Series C in 2019
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.

Healthcare Partners Nevada

Acquisition in 2019
HealthCare Partners Nevada, LLC is a medical group based in Las Vegas, Nevada, with additional locations in Henderson, Mesquite, Pahrump, and Boulder City. Founded in 1996, the company operates a network of medical clinics and specialty care affiliates, offering a wide range of healthcare services. These services include primary care, specialty care, urgent care, and various specialized fields such as cardiology, endocrinology, pediatric care, oncology, and hematology. The organization also provides hospitalist services, house calls, and women’s health services. HealthCare Partners Nevada, LLC emphasizes a patient-centered approach to care and is committed to addressing the long-term health and wellness needs of its patients. Since April 2012, it has operated as a subsidiary of Intermountain Healthcare, Inc.

Velano Vascular

Corporate Round in 2019
Velano Vascular, Inc. is a medical device company based in San Francisco, California, focused on innovating blood collection practices to enhance patient care and reduce associated risks. Founded in 2011, the company has developed the PIVO device, a needle-free and single-use sterile tool designed to draw blood from indwelling peripheral IV lines. This device aims to minimize the number of needle sticks and central line access required for blood collection. By enabling frequent and high-quality blood draws, the PIVO device seeks to deliver a more compassionate and efficient healthcare experience for hospital inpatients while also providing a safer solution for healthcare providers. Velano Vascular is dedicated to addressing the challenges of vascular access and improving the overall efficiency of blood collection in clinical settings.

Redox

Series C in 2019
Redox, Inc. is a healthtech startup incubator based in Madison, Wisconsin, founded in February 2014. The company specializes in developing a comprehensive integration platform that facilitates the secure and efficient exchange of healthcare data among delivery organizations and technology vendors. By standardizing data and maintaining seamless integrations, Redox aims to eliminate technical barriers in healthcare systems, enabling vendors and providers to focus on improving patient experiences. The firm is particularly focused on early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices, striving to make healthcare data more useful and accessible.

Redox

Debt Financing in 2018
Redox, Inc. is a healthtech startup incubator based in Madison, Wisconsin, founded in February 2014. The company specializes in developing a comprehensive integration platform that facilitates the secure and efficient exchange of healthcare data among delivery organizations and technology vendors. By standardizing data and maintaining seamless integrations, Redox aims to eliminate technical barriers in healthcare systems, enabling vendors and providers to focus on improving patient experiences. The firm is particularly focused on early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices, striving to make healthcare data more useful and accessible.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision Ltd. is a developer of an advanced imaging analytics platform that enhances the capabilities of healthcare institutions in diagnosing and managing diseases. Founded in 2014 and based in Shefayim, Israel, the company provides clinicians with tools for identifying patients at risk of various conditions and facilitates improved preventative treatment pathways. Its platform features advanced learning and computer vision diagnostic algorithms, catering to both healthcare providers and machine-learning researchers. Zebra Medical Vision has established strategic collaborations with organizations such as USARAD Holdings and TELUS Ventures, and its products have received FDA clearance for use in hospitals worldwide, including locations in Australia, India, Europe, the U.S., and Latin America. The company is recognized for its role in the AI and machine learning landscape, having raised significant funding to support its innovative solutions in medical imaging.

R1 RCM

Post in 2018
R1 RCM is a revenue cycle management partner based in Chicago, Illinois, established in 2003. The company offers technology-driven solutions designed to enhance the financial performance and patient experience for hospitals, healthcare systems, and physician groups. Through its comprehensive services, R1 RCM provides an end-to-end revenue cycle infrastructure, which includes personnel, technology solutions, and process workflows. The R1 Performance Stack, its proven operating model, integrates seamlessly into existing healthcare organizations, improving operational margins and cash flows while focusing on patient, physician, and staff satisfaction. The majority of the company's revenue is derived from operating fees, reflecting its commitment to delivering sustainable improvements in the revenue cycle for its clients.

Tissue Analytics

Series A in 2018
Tissue Analytics, Inc. is a Baltimore-based company that specializes in developing a mobile application aimed at improving the management of chronic wounds, burns, and skin conditions. Founded in 2014, the company provides a solution for home health agencies, nursing homes, and medical practices to capture patient photographs and perform wound analysis. The platform automatically generates formatted patient reports and enables tracking of treatment progress. It also includes remote evaluation tools and employs advanced algorithms for skin and wound analysis, ensuring secure transmission of protected health information from patients to healthcare providers. Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. and has formed a strategic alliance with MolecuLight Inc.

Empiric Health

Seed Round in 2017
Empiric Health, Inc. is a technology-enabled service platform based in Salt Lake City, Utah, that was founded in 2017. The company focuses on improving clinical outcomes and operational efficiency for health systems by employing data-driven methodologies to facilitate physician practice change. Utilizing proprietary comparative analytics and workflow optimization tools, Empiric Health identifies areas of unwarranted clinical variation, allowing healthcare providers to make evidence-based decisions. This approach not only aims to lower costs but also enhances the quality of episodic care, ultimately supporting care providers in delivering high-value healthcare services. Empiric Health operates as a subsidiary of Oxeon Partners LLC.

Redox

Series B in 2017
Redox, Inc. is a healthtech startup incubator based in Madison, Wisconsin, founded in February 2014. The company specializes in developing a comprehensive integration platform that facilitates the secure and efficient exchange of healthcare data among delivery organizations and technology vendors. By standardizing data and maintaining seamless integrations, Redox aims to eliminate technical barriers in healthcare systems, enabling vendors and providers to focus on improving patient experiences. The firm is particularly focused on early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices, striving to make healthcare data more useful and accessible.

Redox

Series B in 2017
Redox, Inc. is a healthtech startup incubator based in Madison, Wisconsin, founded in February 2014. The company specializes in developing a comprehensive integration platform that facilitates the secure and efficient exchange of healthcare data among delivery organizations and technology vendors. By standardizing data and maintaining seamless integrations, Redox aims to eliminate technical barriers in healthcare systems, enabling vendors and providers to focus on improving patient experiences. The firm is particularly focused on early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices, striving to make healthcare data more useful and accessible.

Zebra Medical Vision

Series B in 2016
Zebra Medical Vision Ltd. is a developer of an advanced imaging analytics platform that enhances the capabilities of healthcare institutions in diagnosing and managing diseases. Founded in 2014 and based in Shefayim, Israel, the company provides clinicians with tools for identifying patients at risk of various conditions and facilitates improved preventative treatment pathways. Its platform features advanced learning and computer vision diagnostic algorithms, catering to both healthcare providers and machine-learning researchers. Zebra Medical Vision has established strategic collaborations with organizations such as USARAD Holdings and TELUS Ventures, and its products have received FDA clearance for use in hospitals worldwide, including locations in Australia, India, Europe, the U.S., and Latin America. The company is recognized for its role in the AI and machine learning landscape, having raised significant funding to support its innovative solutions in medical imaging.

Tute Genomics

Series A in 2015
Tute Genomics is a cloud-based clinical genome interpretation platform based in Provo, Utah, founded in 2012. The company specializes in providing advanced analytical methods for genome analysis, utilizing proprietary machine-learning algorithms to facilitate the analysis and interpretation of entire human genomes. By enabling researchers and clinicians to leverage human genome data, Tute Genomics supports scientific discovery and the development of personalized treatment options. Its platform is designed to help physicians identify genes and biomarkers, ultimately advancing personalized medicine in the life sciences sector.

Tute Genomics

Series A in 2014
Tute Genomics is a cloud-based clinical genome interpretation platform based in Provo, Utah, founded in 2012. The company specializes in providing advanced analytical methods for genome analysis, utilizing proprietary machine-learning algorithms to facilitate the analysis and interpretation of entire human genomes. By enabling researchers and clinicians to leverage human genome data, Tute Genomics supports scientific discovery and the development of personalized treatment options. Its platform is designed to help physicians identify genes and biomarkers, ultimately advancing personalized medicine in the life sciences sector.

VisitPay

Venture Round in 2014
VisitPay LLC is a company that specializes in online patient revenue management solutions, enabling patients to manage their financial accounts effectively. Founded in 2010 and headquartered in Boise, Idaho, with an additional office in Lehi, Utah, VisitPay provides a patient-centered financial engagement platform. This platform consolidates billing information across various healthcare providers and health plans, allowing patients to view, verify, and pay their medical bills with greater clarity. It integrates with multiple billing systems, enhancing the collection process for hospitals and health systems. VisitPay also offers a comprehensive Self-Pay Engine, which includes business intelligence, reporting tools, and consulting services aimed at optimizing self-pay management practices. Through its offerings, the company assists healthcare organizations in managing self-pay receivables, improving payment processes, and implementing effective financial strategies.

Ingram Medical

Series B in 2013
Ingram Medical offers a full range of diabetes testing supplies. Now you can get the quality testing supplies you need, at prices you can afford, delivered right to your home. Serving diabetics for over 15 years. When you submit your information to Ingram Medical by clicking on the FREE METER* icon on our Facebook home page, a Diabetic Benefits Specialist will contact you directly. After collecting some basic information, they will find a medical supplier that best fits your personal needs. You’ll soon be saving time and money on your diabetic testing supplies by receiving reduced costs on your out-of-pocket expenses and having your supplies shipped right to your door.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.